Diabetic complications — including neuropathy (nerve damage), retinopathy (eye damage), nephropathy (kidney damage), and cardiovascular disease — are primarily driven by chronic hyperglycemia and the resulting oxidative stress and advanced glycation end-product (AGE) accumulation. Millets combat diabetic complications through two primary pathways: glycemic control (reducing the primary cause — chronic high blood sugar) and direct antioxidant protection of tissues at risk. Polyphenols in millets inhibit AGE formation by neutralizing reactive carbonyl intermediates. Pearl millet's zinc content supports retinal function, while finger millet's calcium prevents neuropathy-associated bone fragility. A clinical review in Frontiers in Nutrition (2022) found that communities with high millet consumption showed significantly lower rates of diabetic nephropathy.

Key Points

Glycemic control through low GI reduces HbA1c, directly lowering the primary driver of all microvascular diabetic complications

Polyphenols inhibit advanced glycation end-product (AGE) formation — the molecular basis of diabetic tissue damage

Pearl millet zinc supports retinal pigment epithelium function and reduces risk of diabetic retinopathy

Foxtail millet fermented whole grain has been clinically shown to prevent diabetic kidney disease (DKD) in animal and human studies

Anti-inflammatory properties reduce systemic inflammation that accelerates diabetic neuropathy and cardiovascular complications

Evidence Base

Frontiers in Nutrition (2022) and PMC (2023) provide epidemiological and clinical evidence that millet-consuming populations show 25–35% lower rates of common diabetic microvascular complications, attributing the benefit to sustained glycemic control and antioxidant polyphenol protection.